|
D10 concomitant products: egiaustnd, egiaustnd endogia ultra univ std stap, (lot # p5j1184); egiaustnd, egiaustnd endogia ultra univ std stap, (lot # p5h0844); egiaustnd, egiaustnd endogia ultra univ std stap, (lot # p5j1006); sig45axt, tri 2.0 sig45axt 45 xtra thk 15mm, (lot # n5f1811y); sigtrsb60axt, sigtrsb60axt 60mm xtr thk reinforced rel, (lot # n5f1708y); sigtrsb60axt, sigtrsb60axt 60mm xtr thk reinforced rel, (lot # n4k1715y); sig60axt, tri 2.0 sig60axt 60 xtra thk 15mm, (lot # n5e1419y); sig45ctavm, tri 2.0 sig45ctavm 45 ct vsclr med 12mm, (lot # n5h1655y); sig60ctamt, tri 2.0 sig60ctamt 60 ct med thk 12mm, (lot # n5e1962y); sig45axt, tri 2.0 sig45axt 45 xtra thk 15mm, (lot # n5g1756y); sig30ctav, tri 2.0 sig30ctav 30 ct vsclr 12mm, (lot # n5c1843y); sigtrs60amt, tri 2.0 sigtrs60amt 60 med thk 12mm, (lot # 5241038nh); sig45axt, tri 2.0 sig45axt 45 xtra thk 15mm, (lot # n5g1756y); sig45axt, tri 2.0 sig45axt 45 xtra thk 15mm, (lot # n5g1756y); sig60axt, tri 2.0 sig60axt 60 xtra thk 15mm, (lot # n5e1419y); sigtrs60amt, tri 2.0 sigtrs60amt 60 med thk 12mm, (lot # 5241038nh) medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Additional information: g3, h3, h6.H3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.No information re garding the specific customer issue that occurred with the device was available.Upon examination of the sample, it was found that the device partially fired.Visual inspection noted that the reload was partially fired with the interlock engaged.The jaws were open.Staple pushers were visible at various points between the cut lines.Functional testing noted that the reload was loaded into a representative instrument.The reload interlock was tested and found to function properly.The interlock was overridden and the reload was applied to test media.All remaining staples were placed and test media was cleanly transected.The interlock was tested and found to function properly.The product analysis noted evidence that the device was not used as intended.This issue may occur if the open key was pressed prior to the i-beam reaching the end of the reload.Following retraction, the safety interlock feature will engage and prevent the reload from firing a second time.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|